We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $412M
1-Year Est. Return 18.33%
This Fund
S&P 500
This Quarter Est. Return
-7.74%
1 Year Est. Return
+18.33%
3 Year Est. Return
+56.05%
5 Year Est. Return
+49%
10 Year Est. Return
+255.15%
AUM
$1.6B
AUM Growth
-$392M
Cap. Flow
-$203M
Cap. Flow %
-12.69%
Top 10 Hldgs %
25.61%
Holding
503
New
74
Increased
178
Reduced
101
Closed
74

Top Buys

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$24.5M
2
CHD icon
Church & Dwight Co
CHD
+$19.6M
3
ES icon
Eversource Energy
ES
+$18.2M
4
EXPE icon
Expedia Group
EXPE
+$17.6M
5
KMB icon
Kimberly-Clark
KMB
+$17.5M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$31.2M
2
CAG icon
Conagra Brands
CAG
+$27M
3
SEE
Sealed Air
SEE
+$22.8M
4
LLY icon
Eli Lilly
LLY
+$22.1M
5
REG icon
Regency Centers
REG
+$20.3M

Sector Composition

Rank Sector Weight
1 Healthcare 28%
2 Consumer Staples 25.89%
3 Communication Services 10.3%
4 Technology 7.09%
5 Materials 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GM icon
451
General Motors
GM
$77B
– –
-17,560
Closed -$768K
VIP
452
Vulcan Infrastructure and Power
VIP
$34.8M
$0 ﹤0.01%
+10
New +$562
GWW icon
453
W.W. Grainger
GWW
$62.4B
– –
-253
Closed -$130K
HES
454
DELISTED
Hess
HES
– –
-2,061
Closed -$221K
NBP
455
NovaBridge Biosciences American Depositary Shares
NBP
$208M
– –
-150,200
Closed -$2.44M
IP icon
456
International Paper
IP
$19.7B
– –
-2,303
Closed -$106K
JLL icon
457
Jones Lang LaSalle
JLL
$16.7B
– –
-260
Closed -$62K
JPM icon
458
JPMorgan Chase
JPM
$953B
– –
-7,161
Closed -$976K
KGC icon
459
Kinross Gold
KGC
$36.6B
– –
-660,402
Closed -$3.88M
KMI icon
460
Kinder Morgan
KMI
$69.9B
– –
-9,660
Closed -$183K
LII icon
461
Lennox International
LII
$13.5B
– –
-225
Closed -$58K
LUV icon
462
Southwest Airlines
LUV
$19.4B
– –
-4,529
Closed -$207K
LYV icon
463
Live Nation Entertainment
LYV
$40.4B
– –
-447
Closed -$53K
MCK icon
464
McKesson
MCK
$106B
– –
-696
Closed -$213K
MLCO icon
465
Melco Resorts & Entertainment
MLCO
$1.98B
– –
-633,115
Closed -$4.84M
ORIO
466
Orion Digital Corp
ORIO
$23.1M
$0 ﹤0.01%
75
– –
NEE icon
467
NextEra Energy
NEE
$174B
– –
-9,105
Closed -$771K
NI icon
468
NiSource
NI
$19.8B
– –
-567
Closed -$18K
NUE icon
469
Nucor
NUE
$59.2B
– –
-1,565
Closed -$233K
NVAX icon
470
Novavax
NVAX
$1.69B
– –
-173,685
Closed -$12.8M
OC icon
471
Owens Corning
OC
$11B
– –
-1,185
Closed -$108K
OKE icon
472
Oneok
OKE
$60.2B
– –
-822
Closed -$58K
OVV icon
473
Ovintiv
OVV
$17.9B
– –
-1,420
Closed -$77K
PCAR icon
474
PACCAR
PCAR
$65.6B
– –
-2,010
Closed -$118K
PEG icon
475
Public Service Enterprise Group
PEG
$36.7B
– –
-2,773
Closed -$194K
17 18
19
20 21

Similar funds

EC
EntryPoint Capital New York $412M AUM 28.52% 1-Year Est. Return
WIP
WealthCare Investment Partners Portsmouth, Rhode Island $412M AUM 24.95% 1-Year Est. Return
KP
Kiltearn Partners Edinburgh, United Kingdom $412M AUM 26.77% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $412M AUM 34.27% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return
THCM
Taylor Hoffman Capital Management Richmond, Virginia $412M AUM 57.16% 1-Year Est. Return
PA
Prism Advisors Studio City, California $412M AUM 20.58% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $412M AUM 26.77% 1-Year Est. Return

TOBAM's Q2 2022 Portfolio in Review

As of Q2 2022, TOBAM held 503 positions worth $1.6B, down 20% from $1.99B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

TOBAM withdrew a net $203M in Q2 2022, closing 74 positions and reducing 101 holdings. Its most notable exit was Novavax, an estimated $12.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Consumer Staples and Communication Services.

Against the trend, TOBAM opened a new position in Expedia Group worth $11.8M.

  • TOBAM's largest Q2 2022 buy was Expedia Group: 124,451 shares worth $11.8M.
  • TOBAM added most to Quest Diagnostics in Q2 2022, an estimated $24.5M increase.
  • TOBAM's biggest Q2 2022 reduction was Gilead Sciences, cutting an estimated $31.2M.
  • TOBAM fully exited Novavax in Q2 2022, selling an estimated $12.8M.
  • TOBAM's ten largest holdings make up 26% of its $1.6B portfolio in Q2 2022.
  • TOBAM opened 74 new positions and closed 74 in Q2 2022.
  • TOBAM's portfolio value fell 20% quarter-over-quarter to $1.6B.

Based on TOBAM's 13F filing for Q2 2022, filed 2 Aug 2022.